These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33821638)

  • 1. MUC1-Targeted Radiopharmaceuticals in Cancer Imaging and Therapy.
    Maleki F; Rezazadeh F; Varmira K
    Mol Pharm; 2021 May; 18(5):1842-1861. PubMed ID: 33821638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of the Tumor-Specific Antigen-Derived Synthetic Peptides as Potential Candidates for Targeting Breast and Other Possible Human Carcinomas.
    Okarvi SM; AlJammaz I
    Molecules; 2019 Aug; 24(17):. PubMed ID: 31470531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MUC1: a multifaceted oncoprotein with a key role in cancer progression.
    Nath S; Mukherjee P
    Trends Mol Med; 2014 Jun; 20(6):332-42. PubMed ID: 24667139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MUC1-specific cytotoxic T lymphocytes in cancer therapy: induction and challenge.
    Roulois D; Grégoire M; Fonteneau JF
    Biomed Res Int; 2013; 2013():871936. PubMed ID: 23509794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of mono- and multimeric targeted radiopharmaceuticals based on novel cyclen ligands coupled to anti-MUC1 aptamers for the diagnostic imaging and targeted radiotherapy of cancer.
    Borbas KE; Ferreira CS; Perkins A; Bruce JI; Missailidis S
    Bioconjug Chem; 2007; 18(4):1205-12. PubMed ID: 17583928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-MUC1 aptamer: A potential opportunity for cancer treatment.
    Nabavinia MS; Gholoobi A; Charbgoo F; Nabavinia M; Ramezani M; Abnous K
    Med Res Rev; 2017 Nov; 37(6):1518-1539. PubMed ID: 28759115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform of the Membrane Mucin MUC1 Control Adenocarcinoma.
    Posey AD; Schwab RD; Boesteanu AC; Steentoft C; Mandel U; Engels B; Stone JD; Madsen TD; Schreiber K; Haines KM; Cogdill AP; Chen TJ; Song D; Scholler J; Kranz DM; Feldman MD; Young R; Keith B; Schreiber H; Clausen H; Johnson LA; June CH
    Immunity; 2016 Jun; 44(6):1444-54. PubMed ID: 27332733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of pancreatic ductal adenocarcinoma with tumor antigen specific-targeted delivery of paclitaxel loaded PLGA nanoparticles.
    Wu ST; Fowler AJ; Garmon CB; Fessler AB; Ogle JD; Grover KR; Allen BC; Williams CD; Zhou R; Yazdanifar M; Ogle CA; Mukherjee P
    BMC Cancer; 2018 Apr; 18(1):457. PubMed ID: 29685122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances of MUC1 as a target for breast cancer immunotherapy.
    Yang E; Hu XF; Xing PX
    Histol Histopathol; 2007 Aug; 22(8):905-22. PubMed ID: 17503348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Bispecific Aptamer Enhances Immune Cytotoxicity Against MUC1-Positive Tumor Cells by MUC1-CD16 Dual Targeting.
    Li Z; Hu Y; An Y; Duan J; Li X; Yang XD
    Molecules; 2019 Jan; 24(3):. PubMed ID: 30699986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of transmembrane glycoprotein mucin 1 (MUC1) in various types of colorectal cancer and therapies: Current research status and updates.
    Guo M; You C; Dou J
    Biomed Pharmacother; 2018 Nov; 107():1318-1325. PubMed ID: 30257347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tecemotide: an antigen-specific cancer immunotherapy.
    Wurz GT; Kao CJ; Wolf M; DeGregorio MW
    Hum Vaccin Immunother; 2014; 10(11):3383-93. PubMed ID: 25483673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-MUC1 nano-aptamers for triple-negative breast cancer imaging by single-photon emission computed tomography in inducted animals: initial considerations.
    Santos do Carmo F; Ricci-Junior E; Cerqueira-Coutinho C; Albernaz MS; Bernardes ES; Missailidis S; Santos-Oliveira R
    Int J Nanomedicine; 2017; 12():53-60. PubMed ID: 28053523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smart aptamer-modified calcium carbonate nanoparticles for controlled release and targeted delivery of epirubicin and melittin into cancer cells in vitro and in vivo.
    Yazdian-Robati R; Arab A; Ramezani M; Rafatpanah H; Bahreyni A; Nabavinia MS; Abnous K; Taghdisi SM
    Drug Dev Ind Pharm; 2019 Apr; 45(4):603-610. PubMed ID: 30633594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Monoclonal Antibody Targets Mucin1 and Attenuates Growth in Pancreatic Cancer Model.
    Wu G; Maharjan S; Kim D; Kim JN; Park BK; Koh H; Moon K; Lee Y; Kwon HJ
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29987260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucin 1-specific immunotherapy in a mouse model of spontaneous breast cancer.
    Mukherjee P; Madsen CS; Ginardi AR; Tinder TL; Jacobs F; Parker J; Agrawal B; Longenecker BM; Gendler SJ
    J Immunother; 2003; 26(1):47-62. PubMed ID: 12514429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel aptamer-nanoparticle bioconjugates enhances delivery of anticancer drug to MUC1-positive cancer cells in vitro.
    Yu C; Hu Y; Duan J; Yuan W; Wang C; Xu H; Yang XD
    PLoS One; 2011; 6(9):e24077. PubMed ID: 21912664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MUC-1 aptamer targeted superparamagnetic iron oxide nanoparticles for magnetic resonance imaging of pancreatic cancer in vivo and in vitro experiment.
    Zou Q; Zhang CJ; Yan YZ; Min ZJ; Li CS
    J Cell Biochem; 2019 Nov; 120(11):18650-18658. PubMed ID: 31338877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulating MUC1 Function on T Cells.
    Erick TK; Mukherjee P
    Trends Immunol; 2019 Nov; 40(11):980-983. PubMed ID: 31653412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The C-type lectin MGL expressed by dendritic cells detects glycan changes on MUC1 in colon carcinoma.
    Saeland E; van Vliet SJ; Bäckström M; van den Berg VC; Geijtenbeek TB; Meijer GA; van Kooyk Y
    Cancer Immunol Immunother; 2007 Aug; 56(8):1225-36. PubMed ID: 17195076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.